Tirzepatide‡
Regular price $340.00- Details
- Details
- Dosing
- Contraindications
Tirzepatide is an investigational medication that belongs to a class of drugs called dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. Although it is not currently approved for use, it has shown promising results in clinical trials. Here are some potential benefits associated with tirzepatide:
Tirzepatide‡ is a prescription item only and includes a phone consult with the physician. If you have not placed a prescription order with us before, please complete the prescription intake form above for all new orders.
1. Blood sugar control: Tirzepatide has demonstrated effective blood sugar control in clinical trials. By stimulating the release of insulin and suppressing the release of glucagon, it helps lower blood sugar levels, making it potentially beneficial for individuals with type 2 diabetes.
2. Weight management: Tirzepatide has shown significant weight loss effects in clinical trials. It can reduce appetite, increase feelings of fullness, and promote weight loss. This can be particularly helpful for individuals with obesity or those looking to manage their weight.
3. Cardiovascular benefits: Clinical trials have indicated that tirzepatide may have cardiovascular benefits. It has been associated with a reduction in major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death. This is an important consideration for individuals with type 2 diabetes who are at an increased risk of cardiovascular complications.
4. Potential for once-weekly dosing: Tirzepatide is being studied for its potential to be administered once weekly. If approved, this dosing convenience can simplify treatment regimens and enhance medication adherence for individuals with diabetes.
It's important to note that tirzepatide is still undergoing clinical trials, and further research is needed to establish its long-term efficacy and safety profile. As with any medication, the benefits and risks should be discussed with a healthcare professional who can provide personalized advice based on individual circumstances and medical history.
5 - 15 mg subcutaneously weekly
The most commonly reported side effects include nausea, vomiting, diarrhea, stomach pain, and constipation. The risk of serious effects increases in patients with hypoglycemia, kidney problems, and risk of allergic reactions.